| Sky Metals Limited (SKY) ORDINARY FULLY PAID |
Materials |
$203 |
Quarterly Cashflow Report - March 2026
|
29 Apr 2026 8:40AM |
$0.195 |
$0.205 |
risen by
5.13%
|
|
SKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant cash flows from financing activities: $20 million from equity securities.
- Net cash inflow from financing activities: $18.812 million.
- Net cash outflow from operating activities: $444,000.
- Net cash outflow from investing activities: $2.425 million.
- Cash and cash equivalents at quarter end: $20.644 million.
- Payments for exploration and evaluation: $2.34 million.
- No utilization of loan facilities.
- Estimated 7.4 quarters of funding available.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$26,233 |
Notification of cessation of securities - BXB
|
29 Apr 2026 8:40AM |
$21.780 |
$19.640 |
fallen by
9.83%
|
|
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$90 |
Notification of cessation of securities - GHM
|
29 Apr 2026 8:40AM |
$0.475 |
$0.415 |
fallen by
12.63%
|
|
| NOVONIX Limited (NVX) ORDINARY FULLY PAID |
Information Technology |
$149 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
29 Apr 2026 8:39AM |
$0.265 |
$0.150 |
fallen by
43.40%
|
|
NVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Certification of 48C Tax Credit Project by US Government
- Divestiture plan for Battery Technology Solutions business
- Land acquisition for Riverside facility expansion
- USD 57.1 million cash balance as of 31 March 2026
- USD 6.8 million investment in property and equipment
- Expected mass production commencement for Panasonic in H2 2027
- Nasdaq compliance efforts for bid price requirement
- Trade tariffs impact and US production strategy focus
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Locksley Resources Limited (LKY) ORDINARY FULLY PAID |
Materials |
$23 |
Locksley Advances Rare Earth Processing Pathways for Mojave
|
29 Apr 2026 8:39AM |
$0.165 |
$0.060 |
fallen by
63.64%
|
|
LKY - Price-sensitive ASX Announcement
Full Release
Key Points
- Collaboration with Columbia University on rare earth recovery and processing.
- Evaluation of alternative processing routes for the Mojave Project.
- Conceptual processing pathways for bastnaesite-style mineralization.
- Progress in selective recovery and detection technologies.
- Advancement of molten salt electrolysis as an alternative processing method.
- Research to support technical and economic studies at Locksley's Mojave Project.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$90 |
Application for quotation of securities - GHM
|
29 Apr 2026 8:39AM |
$0.475 |
$0.415 |
fallen by
12.63%
|
|
| Core Energy Minerals Ltd (CR3) ORDINARY FULLY PAID |
Materials |
$6 |
Assay Results confirm Itambe Rare Earths Potential
|
29 Apr 2026 8:39AM |
$0.009 |
$0.008 |
fallen by
11.11%
|
|
CR3 - Price-sensitive ASX Announcement
Full Release
Key Points
- Reconnaissance auger drilling at Itambe REE Project confirmed the project's exploration potential.
- Sieved auger samples showed up to 380% higher rare earth element (REE) grades than bulk samples.
- Initial results included 5.6m at 1,429ppm TREO and 2.0m at 1,546ppm TREO.
- Further leaching tests will support the ionic adsorption clay model.
- The Tunas REE Project will involve infill auger drilling to test weathering profile continuity.
- Core Energy acquired the Itambe Project from Rio Tinto's subsidiary in December 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regis Healthcare Limited (REG) ORDINARY FULLY PAID |
Health Care |
$1,968 |
Appointment of Andrew Kinkade as Managing Director and CEO
|
29 Apr 2026 8:39AM |
$6.540 |
$6.510 |
fallen by
0.46%
|
|
REG - Price-sensitive ASX Announcement
Full Release
Key Points
- Andrew Kinkade appointed as Managing Director & CEO of Regis Healthcare.
- Andrew will succeed Dr. Linda Mellors, whose resignation was announced on 22 December 2025.
- Andrew has over 20 years of experience in related sectors.
- His previous role was Managing Director at Bupa Villages & Aged Care.
- He is recognized for operational and cultural transformation and value creation.
- The appointment was facilitated by Korn Ferry through an independent search.
- Andrew's start date is 20 July 2026.
- His remuneration includes a $900,000 salary, with additional incentives based on performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jcurve Solutions Ltd (JCS) ORDINARY FULLY PAID |
Information Technology |
$11 |
Q3FY26 Investor Update
|
29 Apr 2026 8:38AM |
$0.045 |
$0.030 |
fallen by
33.33%
|
|
JCS - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash sales of $2.789M, revenue of $3.048M.
- Total ARR of $2.5M with Jcurve's revenue exceeding reseller revenue.
- Operating profit down to $0.149M due to lower acquisitions and increased spending.
- Stable customer base of 624; cash balance of $2.686M.
- Focus on internal product development, especially ERP and field service management.
- Plans to acquire 100 new customers, necessitating increased sales and R&D investment.
- Anticipated revenue for FY26 between $13M and $13.35M, a 14% to 17% increase from FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$80 |
Update - Notification of buy-back - BOL
|
29 Apr 2026 8:37AM |
$1.795 |
$2.160 |
risen by
20.33%
|
|
| Mont Royal Resources Limited (MRZ) ORDINARY FULLY PAID |
Materials |
$28 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
29 Apr 2026 8:37AM |
$0.180 |
$0.150 |
fallen by
16.67%
|
|
MRZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Mont Royal Resources Limited (ASX: MRZ) released its March 2026 Quarterly Activities and Appendix 5B Cash Flow Report.
- The Ashram Rare Earths & Fluorspar Project's updated Preliminary Economic Assessment (PEA) is near completion with expected release in May 2026.
- Strong potential for resource growth identified in the BD-Zone of the Ashram Project.
- Non-binding MOU signed with Saguenay Port Authority for a proposed hydrometallurgical facility.
- A$5.5 million cash at quarter-end, with expected funding increase post exploration tax rebate.
- A total of $429k spent on exploration activities during the quarter.
- No development or production activities were conducted during the quarter.
- An experienced rare earths executive, Mr. Constantine Karayannopoulos, appointed to the Advisory Board.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ordell Minerals Limited (ORD) ORDINARY FULLY PAID |
Materials |
$32 |
New High-Grade Gold Mineralisation Intersected at Barimaia
|
29 Apr 2026 8:36AM |
$0.765 |
$0.460 |
fallen by
39.87%
|
|
ORD - Price-sensitive ASX Announcement
Full Release
Key Points
- Drilling at Barimaia Project to continue between May and July 2026, targeting high-grade gold mineralisation extensions.
- New high-grade gold mineralisation intersected at McNabs East, part of Barimaia Project.
- Ordell Minerals holds an 80.3% interest in Barimaia, acquired from Genesis Minerals Limited.
- Project located in Murchison region of Western Australia, a Tier-1 mining jurisdiction.
- Exploration aims to define further felsic intrusions and granodiorite intrusion hosted gold mineralisation.
- Recent drill holes show significant gold assay results, including intersections at The Furnace and McNabs North and South areas.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$5,689 |
March 2026 Quarterly presentation
|
29 Apr 2026 8:35AM |
$3.670 |
$3.000 |
fallen by
18.26%
|
|
| MLG Oz Limited (MLG) ORDINARY FULLY PAID |
Materials |
$114 |
MLG to Implement Board and Executive Leadership Changes
|
29 Apr 2026 8:34AM |
$0.735 |
$0.735 |
fallen by
0%
|
|
| Syrah Resources Limited (SYR) ORDINARY FULLY PAID |
Materials |
$244 |
March 2026 Quarterly Activities and Cashflow Report
|
29 Apr 2026 8:34AM |
$0.110 |
$0.105 |
fallen by
4.55%
|
|
SYR - Price-sensitive ASX Announcement
Full Release
Key Points
- Syrah Resources Limited's graphite production at Balama reached 24kt with high quality.
- A multi-year offtake agreement was signed with NextSource.
- AAM production at Vidalia focused on customer qualification.
- A net cash outflow of US$26.53 million was reported from operating activities.
- US$72 million was raised through equity for operational support.
- Strategic funding proposals received from DFC, DOE, and AustralianSuper.
- The US DOE loan for Vidalia and DFC loan for Balama were discussed.
- Efforts to resolve loan defaults due to operational interruptions were ongoing.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Structural Monitoring Systems Plc (SMN) CHESS DEPOSITARY INTERESTS 1:1 |
Information Technology |
$59 |
Investor Webinar & Teleconference Presentation
|
29 Apr 2026 8:33AM |
$0.395 |
$0.380 |
fallen by
3.80%
|
|
| Avecho Biotechnology Limited (AVE) ORDINARY FULLY PAID |
Health Care |
$69 |
March 2026 Quarterly Activities Report & Appendix 4C
|
29 Apr 2026 8:33AM |
$0.011 |
$0.018 |
risen by
63.64%
|
|
AVE - Price-sensitive ASX Announcement
Full Release
Key Points
- Avecho's Phase III CBD insomnia trial update.
- Licensing agreement with Sandoz AG includes milestone payments and royalties.
- Projected growth in the Australian CBD market and global insomnia therapeutics market.
- CEO presentations at healthcare conferences.
- Financial activities and cash flow statements for the quarter.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Prospect Resources Limited (PSC) ORDINARY FULLY PAID |
Materials |
$233 |
Further Impressive Gold Results from Nyungu Central
|
29 Apr 2026 8:32AM |
$0.315 |
$0.280 |
fallen by
11.11%
|
|
PSC - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant gold mineralisation confirmed at Nyungu Central.
- Notable gold assay results from various drill holes have been reported.
- The gold re-assay programme includes 59 holes, with results pending for some.
- There is strong potential to upgrade Mumbezhi Copper Project economics with gold and cobalt credits.
- An updated Mineral Resource Estimate (MRE) for Nyungu Central is expected in Q2 2026.
- Phase 3 drilling at Mumbezhi to commence in early May focusing on regional growth targets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| RocketDNA Ltd (RKT) ORDINARY FULLY PAID |
Information Technology |
$26 |
Investor Presentation - April 2026
|
29 Apr 2026 8:30AM |
$0.023 |
$0.021 |
fallen by
8.70%
|
|
| Odyssey Gold Ltd (ODY) ORDINARY FULLY PAID |
Materials |
$41 |
March 2026 Quarterly Report
|
29 Apr 2026 8:29AM |
$0.037 |
$0.029 |
fallen by
21.62%
|
|
ODY - Price-sensitive ASX Announcement
Full Release
Key Points
- Odyssey Gold Ltd commenced 2026 field work at Tuckanarra Gold Project.
- A reverse circulation drill rig began resource definition drilling at key deposits.
- A Scoping Study is underway to update Mineral Resource Estimate.
- Current MRE at Tuckanarra is 5.14Mt @ 2.5g/t for 407,000oz of gold.
- A Native Vegetation Clearing Permit application was lodged in April 2026.
- Company raised $9.0 million through a share placement.
- Engagement with regional processing plants for a low-cost production pathway.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| TrivarX Ltd (TRI) ORDINARY FULLY PAID |
Health Care |
$24 |
Dr Danielle Meyrick appointed as CEO
|
29 Apr 2026 8:29AM |
$0.016 |
$0.021 |
risen by
31.25%
|
|
TRI - Price-sensitive ASX Announcement
Full Release
Key Points
- Dr Danielle Meyrick appointed as CEO effective 1 June 2026
- TrivarX Ltd focuses on the Stabl-Im platform for imaging solutions
- Dr Meyrick has over 20 years of experience in related fields
- Her previous roles include positions at Telix Pharmaceuticals and ITM Isotopes
- Stabl-Im utilizes stable isotope labelling for non-invasive imaging
- Dr Meyrick's remuneration includes $300,000 salary and performance incentives
- Company aims for clinical and regulatory advancements under her leadership
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Toubani Resources Inc (TRE) ORDINARY FULLY PAID |
Materials |
$279 |
Mali Update
|
29 Apr 2026 8:29AM |
$0.435 |
$0.365 |
fallen by
16.09%
|
|
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$102 |
Trading Halt
|
29 Apr 2026 8:29AM |
$0.405 |
$0.560 |
risen by
38.27%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- Trading halt requested by LTR Pharma Limited (ASX: LTP) pending data analysis and announcement.
- Halt relates to interim clinical trial results of SPONTAN® Nasal Spray for Erectile Dysfunction.
- Trading halt expected to last until announcement release or trading commencement on 1 May 2026.
- LTR Pharma confirms no awareness of reasons against granting the trading halt.
- LTR Pharma is a pharmaceutical company with a focus on intranasal drug delivery technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cluey Ltd (CLU) ORDINARY FULLY PAID |
Consumer Discretionary |
$2 |
March 2026 Quarterly Actiivities Report and Appendix 4C
|
29 Apr 2026 8:29AM |
$0.020 |
$0.005 |
fallen by
75%
|
|
CLU - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating cash outflow improved to $0.79 million, a 16% reduction from the previous corresponding period.
- Group gross profit margin increased to 58.1%.
- New student growth of 5% in the online tutoring division.
- Release of Stage 1 of AI-driven Cluey+ products.
- Underlying EBITDA loss of $2.11 million, reflecting increased customer acquisition costs.
- Total cash on hand as of 31 March 2026 was $4.81 million.
- Net cash from operating activities was ($0.79) million for Q3 FY26.
- Net cash used in investing activities was ($0.34) million, an increase due to investment in Cluey+.
- Payments to directors and related parties totaled $99,000.
- Customer acquisition costs impacted by 13% inflation in paid search and social media.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| GWA Group Limited (GWA) ORDINARY FULLY PAID |
Industrials |
$610 |
Update - Notification of buy-back - GWA
|
29 Apr 2026 8:28AM |
$2.010 |
$2.300 |
risen by
14.43%
|
|
Call 1300 880 160
Start a chat
Schedule a call
